Association of miR-21 and miR-335 to microsatellite instability and prognosis in stage III colorectal cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of miR-21 and miR-335 to microsatellite instability and prognosis in stage III colorectal cancer
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume -, Issue -, Pages 1-10
Publisher
IOS Press
Online
2021-12-22
DOI
10.3233/cbm-210353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis
- (2021) Marta Correia de Sousa et al. Cancers
- Association between baseline circulating tumor cells, molecular tumor profiling and clinical characteristics in a large cohort of chemo-naïve metastatic colorectal cancer patients prospectively collected
- (2020) J. Sastre et al. Clinical Colorectal Cancer
- A new prognostic and predictive tool for shared decision making in stage III colon cancer
- (2020) Alberto F. Sobrero et al. EUROPEAN JOURNAL OF CANCER
- Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials
- (2020) Romain Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
- (2019) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location
- (2019) Robin Mjelle et al. BMC CANCER
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
- (2017) Qiliang Peng et al. Oncotarget
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Tissue microRNA-21 expression predicted recurrence and poor survival in patients with colorectal cancer – a meta-analysis
- (2016) Yunxian Yu et al. OncoTargets and Therapy
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
- (2016) Julien Taieb et al. JNCI-Journal of the National Cancer Institute
- Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab
- (2016) Julien Taieb et al. JAMA Oncology
- Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse
- (2015) Won Kyung Kang et al. BMC GASTROENTEROLOGY
- Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells
- (2015) Yanxia Lu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer
- (2014) M. J. Sotelo et al. ANNALS OF ONCOLOGY
- MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting ZEB2
- (2014) ZhiFeng Sun et al. MEDICAL ONCOLOGY
- The Prognostic Value of MicroRNAs Varies with Patient Race/Ethnicity and Stage of Colorectal Cancer
- (2013) L. C. Bovell et al. CLINICAL CANCER RESEARCH
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease
- (2011) Michael M. Vickers et al. CLINICAL & EXPERIMENTAL METASTASIS
- MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
- (2010) N. Valeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
- (2009) P. Wang et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now